top of page


Partners from African and European institutions met from the 16th to the 18th of April in Mozambique’s capital, Maputo to discuss the next steps of the PreFIT project.


Funded by the European and Developing Countries Clinical Trials Partnership (EDCTP), Predicting the Future: Incipient Tuberculosis (PreFIT) aims at reducing the morbidity and mortality of tuberculosis in Africa through early detection of the disease before symptoms appear.


The three sites, Stellenbosch University in Cape Town, Makerere University in Uganda, and Manhiça Health Research Centre (CISM) in Mozambique ended the recruitment in January 2024. In Mozambique alone, 1107 household contacts from 462 TB index cases were recruited “We express our gratitude to all participants who have graciously agreed to be part of the PreFIT project” highlights Dinis Nguenha, Principal Investigator at the Manhiça site.


Alberto García-Basteiro, Sozinho Acacio, Dinis Nguenha, Patricia Manjate, Marta Cossa, and Alessandra Guida from CISM updated partners on the latest progress made by the Manhiça Tuberculosis Initiative (MTBI) in the framework of the PreFIT study and addressed upcoming challenges. With just one year to go before the end of the project, PreFIT has now reached a crucial stage, as results will be ready to be shared after the follow-up of participants.


For more information about the last Annual Meeting in Maputo, you can read the full newpiece by clicking here

0 views0 comments


bottom of page